Category: Abbott LaboratoriesSyndicate content

Abbott logs Q1 profits beat as branded generics sales jump

April 22, 2015 by MassDevice

Abbott's 1st-quarter profits top expectations as sales of its branded generic drugs jump.

Abbott logs Q1 profits beat as branded generics sales jump

ABT unveils OTC glucose meter | Regulatory news for the week of April 20, 2015

April 21, 2015 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Abbott unveils over-the-counter glucose meter; Medtronic's Micra leadless pacemaker wins EU approval; FDA clears Conventus PH shoulder cage; FDA approves AcuFocus Kamra inlay; Cardiac Assist wins CE Mark for emergency cannula

Abbott unveils over-the-counter glucose meter

April 17, 2015 by Val Kennedy

Abbott unveils over-the-counter glucose meter

April 17, 2015 by Val Kennedy

Abbott Laboratories receives FDA approval for a new, budget-priced glucose monitor that can be purchased without a prescription.

Abbott unveils over-the-counter glucose meter

Abbott (NYSE:ABT) said it received FDA approval for a new, budget-priced glucose monitor that can be purchased without a prescription.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

BAX drops FloSeal case against J&J | Medtech legal news for the week of April 13, 2015

April 13, 2015 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Baxter drops FloSeal case against J&J; Feds: We got $119m in fraud penalties from medtech companies last year; Insurer, DJO Global settle pain pump suit

Baxter drops FloSeal case against J&J

April 6, 2015 by Brad Perriello

YYmeta

Feds: We got $119m in fraud penalties from medtech companies last year

April 8, 2015 by Brad Perriello

The U.S. Health & Human Services Dept. and the Justice Dept. say they collected some $119 million in healthcare fraud penalties from medical device companies during fiscal 2014.

Feds: We got $119m in fraud penalties from medtech companies last year

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

India OKs Abbott's FreeStyle Libre Pro glucose monitoring system

April 6, 2015 by Brad Perriello

India approves Abbott's FreeStyle Libre Pro Flash system, featuring a patient-worn sensor that logs blood sugar levels for up to 14 days.

India OKs Abbott's glucose monitoring system

Regulators in India approved a glucose monitoring system made by Abbott (NYSE:ABT) that's designed to track patients' blood sugar levels for up to 2 weeks.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

RIP former Evalve CEO Powell | Personnel Moves

March 23, 2015 by Brad Perriello

Ferolyn Powell, the former CEO of Evalve who led it to a $410 million acquisition by Abbott, is killed in a motorbike accident in Thailand.

RIP former Evalve CEO Powell | Personnel Moves

Former Evalve CEO Ferolyn Powell, who led the MitraClip developer to a $410 million acquisition by Abbott (NYSE:ABT), died this month in a motorbike accident in northern Thailand, her family said yesterday.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.